The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hryniewicz, A.
Right arrow Articles by Franchini, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hryniewicz, A.
Right arrow Articles by Franchini, G.
The Journal of Immunology, 2007, 178: 3492-3504.
Copyright © 2007 by The American Association of Immunologists, Inc.

Interleukin-15 but Not Interleukin-7 Abrogates Vaccine-Induced Decrease in Virus Level in Simian Immunodeficiency Virusmac251-Infected Macaques1

Anna Hryniewicz2,*,{dagger}, David A. Price2,{ddagger}, Marcin Moniuszko2,*,{dagger}, Adriano Boasso§, Yvette Edghill-Spano*,*, Sadie M. West, David Venzon||, Monica Vaccari*, Wen-Po Tsai*, Elzbieta Tryniszewska*,{dagger}, Janos Nacsa*, Francois Villinger#, Aftab A. Ansari#, Christopher J. Trindade*, Michel Morre**, David Brooks{dagger}{dagger}, Philip Arlen{dagger}{dagger}, Helen J. Brown{dagger}{dagger}, Christina M. R. Kitchen*, Jerome A. Zack{dagger}{dagger}, Daniel C. Douek{ddagger}, Gene M. Shearer§, Mark G. Lewis*, Richard A. Koup and Genoveffa Franchini3,*

* Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892; {dagger} Medical University of Bialystok, Bialystok, Poland; {ddagger} Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892; § Experimental Immunology Branch, National Cancer Institute, Bethesda, MD 20892; Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892; || Biostatistics and Data Management Section, National Cancer Institute, Bethesda, MD 20892; # Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322; ** Cytheris, Issy les Moulineaux, France; {dagger}{dagger} David Geffen School of Medicine, University of California, Los Angeles, CA 90095; * Bioqual, Rockville, MD 20850; and * Southern Research Institute, Frederick, MD 21701; * Department of Biostatistics, UCLA School of Public Health, University of California, Los Angeles, CA 90095

The loss of CD4+ T cells and the impairment of CD8+ T cell function in HIV infection suggest that pharmacological treatment with IL-7 and IL-15, cytokines that increase the homeostatic proliferation of T cells and improve effector function, may be beneficial. However, these cytokines could also have a detrimental effect in HIV-1-infected individuals, because both cytokines increase HIV replication in vitro. We assessed the impact of IL-7 and IL-15 treatment on viral replication and the immunogenicity of live poxvirus vaccines in SIVmac251-infected macaques (Macaca mulatta). Neither cytokine augmented the frequency of vaccine-expanded CD4+ or CD8+ memory T cells, clonal recruitment to the SIV-specific CD8+ T cell pool, or CD8+ T cell function. Vaccination alone transiently decreased the viral set point following antiretroviral therapy suspension. IL-15 induced massive proliferation of CD4+ effector T cells and abrogated the ability of vaccination to decrease set point viremia. In contrast, IL-7 neither augmented nor decreased the vaccine effect and was associated with a decrease in TGF-beta expression. These results underscore the importance of testing immunomodulatory approaches in vivo to assess potential risks and benefits for HIV-1-infected individuals.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research and the National Institute of Allergy and Infectious Diseases, Division of AIDS.

2 A.H., D.A.P., and Ma. M. contributed equally to the work.

3 Address correspondence and reprint requests to Dr. Genoveffa Franchini, National Cancer Institute, Building 41/Room D804, Bethesda, MD 20892. E-mail address: franchig{at}mail.nih.gov

4 Abbreviations used in this paper: Treg, regulatory T cell; ART, antiretroviral therapy; gpe, gag, pol, and env genes of SIVmac251; IUPM, infectious units per million cells; Mamu, Macaca mulatta.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. L. Kinter, E. J. Godbout, J. P. McNally, I. Sereti, G. A. Roby, M. A. O'Shea, and A. S. Fauci
The Common {gamma}-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands
J. Immunol., November 15, 2008; 181(10): 6738 - 6746.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Demberg, J. D. Boyer, N. Malkevich, L. J. Patterson, D. Venzon, E. L. Summers, I. Kalisz, V. S. Kalyanaraman, E. M. Lee, D. B. Weiner, et al.
Sequential Priming with Simian Immunodeficiency Virus (SIV) DNA Vaccines, with or without Encoded Cytokines, and a Replicating Adenovirus-SIV Recombinant Followed by Protein Boosting Does Not Control a Pathogenic SIVmac251 Mucosal Challenge
J. Virol., November 1, 2008; 82(21): 10911 - 10921.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Vaccari, J. Mattapallil, K. Song, W.-P. Tsai, A. Hryniewicz, D. Venzon, M. Zanetti, K. A. Reimann, M. Roederer, and G. Franchini
Reduced Protection from Simian Immunodeficiency Virus SIVmac251 Infection Afforded by Memory CD8+ T Cells Induced by Vaccination during CD4+ T-Cell Deficiency
J. Virol., October 1, 2008; 82(19): 9629 - 9638.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Cecchinato, E. Tryniszewska, Z. M. Ma, M. Vaccari, A. Boasso, W.-P. Tsai, C. Petrovas, D. Fuchs, J.-M. Heraud, D. Venzon, et al.
Immune Activation Driven by CTLA-4 Blockade Augments Viral Replication at Mucosal Sites in Simian Immunodeficiency Virus Infection
J. Immunol., April 15, 2008; 180(8): 5439 - 5447.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.